Haishan Sun

Carrie Sun has extensive experience in non-litigation legal matters such as corporate reorganization, M&A, PE/VC, overseas listing and foreign direct investment. Carrie has served companies in the industries of pharmaceutical, manufacturing, telecommunication, automobile, real estate, mining, service, etc. Carrie has extensive experience in investment & financing and capital market, and some representative projects including: Shenzhen Capital Value Partners Greater Bay Area Opportunity Limited Partnership Fund’s acquisition of 2.09% issued shares of Fengxiang Co (09977.HK), Dawnrays Pharma’s (02348.HK) selling of shares of AD Pharmaceuticals, Hong Kong Sincere Watch's (00444.HK) acquisition of Hainan Boao Lecheng, PanAsialum Holdings Company Limited’s (02078.HK) sale of its domestic subsidiaries, representing Haitong in its issuance of short-term private placement bonds to a number of domestic real estate companies, Taiping Financial Holdings Company Limited’s investment in ClouDr Group Limited (09955.HK), CLSA's investment in a Hangzhou baby products company, Orchid Asia's investment in online-consuming companies in Shenzhen and Guangzhou, CGN's acquisition of LNG Gas station project, Goldman Sachs' equity acquisition on Shenzhen Mindray and its listing on NASDAQ and subsequent series of additional issuance, DBS Bank’s investment in Jinhao, Heng Ding and New World's acquisition of convertible bond of an agricultural company in Sichuan, Thomson's Investment on Konka, Hyosung's acquisition of a Chinese transformer manufacturer, Ashmore Investment Management Limited’s acquisition of Shenzhen Minrun Agricultural Products Chain Commercial Co., Ltd., 7daysinn’s private equity financing of Warburg Pincus’s and Merrill Lynch’s investors, PingAn’s investment in Ciming Checkup, Enpack’s investment in a large-scale electronic product manufacturing enterprise project in Huizhou, DCH HOLDINGS’s acquisition of a famous 4S store in Shenzhen, US Rotorcraft Companies and Chinese companies’ directly investment in the establishment of a domestic aircraft manufacturing company, China Overseas Holdings Limited’s overseas bond issuance, the public listing on the NYSE and subsequent capital increase issuance of Mindray International; public offering and listing on the main board of the HKEX of Belle, Yide International (01396.HK), Wuzhou International (01369.HK), Hung Fook Tong (01446.HK), Ten Pao Group (01979.HK), Vincent Medical Holdings (01612.HK), Smart-Core Holdings (02166.HK), Mengke Holdings (01629.HK), Trio Industrial Electronics (01710.HK), Oneforce Holdings (01933.HK), Tian Chang Group (02182.HK), Tian Yuan Group (06119.HK), Maike Tube Industry Holdings Limited (01553.HK), Nayuki Holdings Limited (02150.HK), General Education (02175.HK); public listing on the Growth Enterprise Market of the HKEX of Golden Power Group (03919.HK) and ZC Tech GP (08511.HK); the initial public offering and listing on NASDAQ of Connect Biopharma (CNTB.US) and Jin Medical International Ltd. (ZJYL.US); MicroPort Scientific Corporation’s (00853.HK) overseas bond issuance, etc. · Global Law Office